|
Oct 10
|
Terumo (TRUMY) Is a Great Choice for 'Trend' Investors, Here's Why
|
|
Sep 20
|
Are You Looking for a Top Momentum Pick? Why Terumo Corp. (TRUMY) is a Great Choice
|
|
Aug 6
|
Terumo Establishes Corporate Venture Capital "Terumo Ventures"
|
|
Jul 25
|
Terumo (TRUMY) Unit Reveals WEB 17 Device Effective in Aneurysms
|
|
Jul 23
|
MicroVention Announces Release of CLinical EValuation of WEB™ 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms
|
|
Jan 10
|
Recent Price Trend in Terumo Corp. (TRUMY) is Your Friend, Here's Why
|
|
Aug 8
|
Orchestra BioMed™ Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon™ in Patients with Coronary In-Stent Restenosis
|